Chemed Management

Management Kriterienprüfungen 3/4

Chemed's CEO ist Kevin McNamara , ernannt in Aug 1994, hat eine Amtszeit von 29.83 Jahren. Die jährliche Gesamtvergütung beträgt $12.63M , bestehend aus 12.7% Gehalt und 87.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.71% der Aktien des Unternehmens, im Wert von $57.70M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 24.1 Jahre bzw. 15.1 Jahre.

Wichtige Informationen

Kevin McNamara

Geschäftsführender

US$12.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	12.7%
Amtszeit als Geschäftsführer	29.8yrs
Eigentum des Geschäftsführers	0.7%
Durchschnittliche Amtszeit des Managements	24.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	15.1yrs

Jüngste Management Updates

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Recent updates

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Is Chemed (NYSE:CHE) A Risky Investment?

Jun 29

Chemed announces a five-year $550M amended and restated senior secured credit facility

Jun 29

Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Jun 14

Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

May 14

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kevin McNamara im Vergleich zu den Einnahmen von Chemed verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	US$283m
Dec 31 2023	US$13m	US$2m	US$273m
Sep 30 2023	n/a	n/a	US$245m
Jun 30 2023	n/a	n/a	US$226m
Mar 31 2023	n/a	n/a	US$240m
Dec 31 2022	US$12m	US$1m	US$250m
Sep 30 2022	n/a	n/a	US$262m
Jun 30 2022	n/a	n/a	US$277m
Mar 31 2022	n/a	n/a	US$267m
Dec 31 2021	US$12m	US$1m	US$269m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	US$303m
Mar 31 2021	n/a	n/a	US$329m
Dec 31 2020	US$12m	US$1m	US$319m
Sep 30 2020	n/a	n/a	US$271m
Jun 30 2020	n/a	n/a	US$263m
Mar 31 2020	n/a	n/a	US$231m
Dec 31 2019	US$10m	US$1m	US$220m
Sep 30 2019	n/a	n/a	US$209m
Jun 30 2019	n/a	n/a	US$201m
Mar 31 2019	n/a	n/a	US$205m
Dec 31 2018	US$9m	US$1m	US$206m
Sep 30 2018	n/a	n/a	US$206m
Jun 30 2018	n/a	n/a	US$190m
Mar 31 2018	n/a	n/a	US$113m
Dec 31 2017	US$8m	US$1m	US$98m

Vergütung im Vergleich zum Markt: KevinDie Gesamtvergütung ($USD12.63M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD8.44M).

Entschädigung vs. Einkommen: KevinDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Kevin McNamara (70 yo)

29.8yrs

Amtszeit

US$12,625,106

Vergütung

Mr. Kevin J. McNamara has been the Chief Executive Officer of Chemed Corporation since May 2001 and has been its President since August 2, 1994. Previously, Mr. McNamara served as an Executive Vice Preside...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kevin McNamara	CEO, President & Director	29.8yrs	US$12.63m	0.71% $ 57.0m
Michael Witzeman	VP, Controller	12.1yrs	US$2.93m	0.020% $ 1.6m
Spencer Lee	Executive Vice President	24.1yrs	US$3.37m	0.13% $ 10.5m
Thomas Hutton	VP & Director	36.3yrs	keine Daten	0.58% $ 46.9m
Nicholas Westfall	Executive Vice President	8yrs	US$4.71m	0.054% $ 4.3m
Lisa Reinhard	VP, Chief Administrative Officer & Secretary	29.6yrs	keine Daten	keine Daten
Sherri Warner	Director of Investor Relations	no data	keine Daten	keine Daten
Brian Judkins	VP, Secretary & Chief Legal Officer	3.8yrs	keine Daten	0.0094% $ 757.3k
Nathan McNamara	VP & Chief Strategy Officer	no data	keine Daten	keine Daten

24.1yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: CHEDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (24.1 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kevin McNamara	CEO, President & Director	37.4yrs	US$12.63m	0.71% $ 57.0m
Thomas Hutton	VP & Director	39.4yrs	keine Daten	0.58% $ 46.9m
Thomas Rice	Independent Director	15.1yrs	US$278.27k	0.040% $ 3.2m
Sandra Laney	Director Emeritus	15.1yrs	US$157.02k	keine Daten
Patrick Grace	Independent Director	28.4yrs	US$308.60k	0.022% $ 1.7m
George Walsh	Independent Chairman	29.4yrs	US$453.15k	0.027% $ 2.2m
Andrea Lindell	Independent Director	16.1yrs	US$272.77k	0.043% $ 3.5m
Christopher Heaney	Independent Director	4.1yrs	US$279.43k	0.014% $ 1.1m
Ron DeLyons	Independent Director	4.1yrs	US$278.27k	0.0092% $ 739.7k
John Mount	Independent Director	1.8yrs	US$278.27k	0.0043% $ 347.8k
Eileen McCarthy	Independent Director	1.1yrs	US$238.52k	0.0038% $ 307.6k

15.1yrs

Durchschnittliche Betriebszugehörigkeit

70yo

Durchschnittliches Alter

Erfahrener Vorstand: CHEDie Vorstandsmitglieder sind sehr erfahren ( 15.1 ).

Chemed Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Chemed Corporation, Annual General Meeting, May 20, 2024

Executive Vice President exercised options and sold US$3.8m worth of stock

Recent updates

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock

Independent Director recently sold US$160k worth of stock

Independent Director notifies of intention to sell stock

CEO, President & Director recently sold US$2.2m worth of stock

CEO, President & Director exercised options and sold US$412k worth of stock

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

CEO, President & Director recently sold US$1.6m worth of stock

Executive VP & CFO recently sold US$2.1m worth of stock

CEO, President & Director recently sold US$1.0m worth of stock

CEO, President & Director exercised options to buy US$1.2m worth of stock.

Full year 2022 earnings: EPS misses analyst expectations

Chemed Q4 2022 Earnings Preview

Chemed Corporation Declares Quarterly Cash Dividend Payable on March 17, 2023

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Chemed Corporation to Report Q4, 2022 Results on Feb 23, 2023

Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

VP & Director exercised options and sold US$226k worth of stock

CEO, President & Director recently sold US$1.0m worth of stock

Executive VP & CFO exercised options and sold US$2.3m worth of stock

Executive VP & CFO recently sold US$4.0m worth of stock

CEO, President & Director recently sold US$966k worth of stock

Chemed Corporation Declares Quarterly Cash Dividend on the Capital Stock, Payable on December 5, 2022

Chemed declares $0.38 dividend